KFKarina Farias

Karina Farias

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects


Karina Farias has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Anthony A Sauve

    Department of Pharmacology, Weill Cornell Medicine , 1300 York Avenue, New York, NY 10021

    1 shared publication
  • Huiyong Cheng

    Department of Pharmacology, Weill Cornell Medicine , 1300 York Avenue, New York, NY 10021

    1 shared publication
  • Jacob B. Geri

    Department of Pharmacology, Weill Cornell Medical College, New York, USA

    1 shared publication
  • Qingxia Huang

    Department of Pharmacology, Weill Cornell Medicine , 1300 York Avenue, New York, NY 10021

    1 shared publication
  • Qiuying Chen

    Department of Pharmacology, Weill Cornell Medicine , 1300 York Avenue, New York, NY 10021

    1 shared publication
  • Steven S Gross

    Department of Pharmacology, Weill Cornell Medicine , 1300 York Avenue, New York, NY 10021

    1 shared publication

Latest Publications

  • NAD+ replenishment reduces cardiomyocyte senescence and improves diastolic function in the aged male heart

    by Qingxia Huang, Yongjie Wang, Karina Farias, Xinliu Zeng, Qiuying Chen, Huiyong Cheng, Vijaya B Baki, Steven S Gross, Jacob Geri, Anthony A Sauve, et al.

    Aims: Cardiomyocyte senescence is a hallmark of cardiac ageing and closely associated with diastolic dysfunction and heart failure in older adults. Strategies to effectively delay or reverse cardiomyocyte senescence in the aged heart remain limited. We investigated whether NAD+ replenishment regulates cardiomyocyte senescence and cardiac function in ageing. Methods and results: Ventricular NAD+ metabolism, senescence markers, and cardiac function were assessed in young and aged mice of both sexes. Aged male mice exhibited reduced cardiac NAD+ levels due to impaired biosynthesis, limited mitochondrial mobilization, and increased consumption, leading to suppressed SIRT1 and SIRT6 activity and accumulation of senescent cardiomyocytes. These changes were accompanied by diastolic dysfunction, myocardial hypertrophy, and fibrosis. In cultured cardiomyocytes, NAD+ depletion induced cellular senescence, which was reversed by supplementation with the NAD+ precursors nicotinamide riboside (NR) and dihydronicotinamide riboside (NRH). In aged male mice, two months of NR or NRH treatment suppressed senescence markers, improved diastolic function, and reduced hypertrophy and fibrosis. Mechanistically, both NR and NRH activated SIRT1 and suppressed cell cycle arrest markers. NRH induced more robust SIRT1 activation, which deacetylated SIRT6, promoting its binding to histones and enhancing DNA damage repair. In contrast, aged female mice exhibited diastolic dysfunction without significant decline in cardiac NAD+ levels and did not respond to NR or NRH treatment. Conclusion: NAD+ is a critical regulator of cardiomyocyte senescence in ageing male hearts. NAD+ replenishment, particularly with NRH, reverses senescence-associated cardiac dysfunction through coordinated activation of SIRT1 and SIRT6. The sex-specific differences observed highlight distinct mechanisms underlying cardiac ageing and emphasize the importance of considering biological sex in the development of NAD+-based therapeutic strategies.